We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Fast facts: Multiple myeloma and plasma cell dyscrasias

Fast facts: Multiple myeloma and plasma cell dyscrasias (2015)

Multiple myeloma accounts for approximately 0.8% of cancers worldwide, with about 114 000 new cases each year. Rapid progress is being made in the development of new treatments and, although myeloma is incurable at present, survival has almost tripled over the past 10 years and it is now projected that a third of patients will survive more than 10 years after diagnosis. Fast Facts: Multiple Myeloma and Plasma Cell Dyscrasias emphasizes the importance of early diagnosis for a favourable outcome, covers the ever-increasing role of genetics in diagnosis and treatment, and discusses new and gold-standard treatments. A chapter on supportive care also features and briefs the reader on long-term outcomes and quality of life issues. Although primarily intended for health care professionals, this highly readable resource may be of interest to patients wanting to know more about multiple myeloma and plasma cell dyscrasias. Written for doctors, read by patients too. (Publisher)

Author(s)
Ramasamy K, Lonial S
Place of publication
Abingdon
Publisher
Date of publication
2015
Pages
152pp
ISBN
9781908541956
Price
£15.00
Subject(s)
Format
Book
Language
English
Download this resource
Book reviews
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm